|
|
||||||||
The Annals of Thoracic Surgery, Vol 54, 1236-1243, Copyright © 1992 by The Society of Thoracic Surgeons
SW Downing and LH Edmunds Jr
Cardiopulmonary bypass is associated with bleeding and thrombotic
complications, massive fluid shifts, and cellular and hormonal defense
reactions that are collectively termed "the whole body inflammatory
response." A host of vasoactive substances are produced, released or
altered during cardiopulmonary bypass. These hormones, autacoids, and
cytokines react with specific receptor proteins distributed throughout the
body, and mediate the vascular smooth muscle and endothelial cell
contractions that are responsible for much of the morbidity associated with
open heart operations. This essay briefly reviews the actions, sources, and
perturbations of the approximately 25 vasoactive substances known or
believed to be altered by cardiopulmonary bypass, and provides an
introductory reference list.
ARTICLES
Release of vasoactive substances during cardiopulmonary bypass
Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia.
This article has been cited by other articles:
![]() |
J. W. Hammon Extracorporeal Circulation: Perfusion System Card. Surg. Adult, January 1, 2008; 3(2008): 350 - 370. [Full Text] |
||||
![]() |
J. W. Hammon Extracorporeal Circulation: The Response of Humoral and Cellular Elements of Blood to Extracorporeal Circulation Card. Surg. Adult, January 1, 2008; 3(2008): 370 - 389. [Full Text] |
||||
![]() |
J. W. Hammon Extracorporeal Circulation: Organ Damage Card. Surg. Adult, January 1, 2008; 3(2008): 389 - 414. [Full Text] |
||||
![]() |
G.-W. He, M.-H. Liu, Q. Yang, A. Furnary, and A. P.C. Yim Role of Endothelin-1 Receptor Antagonists in Vasoconstriction Mediated by Endothelin and Other Vasoconstrictors in Human Internal Mammary Artery Ann. Thorac. Surg., November 1, 2007; 84(5): 1522 - 1527. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Orr, J. M. Taylor, S. Cartland, P. G. Bannon, C. Geczy, and L. Kritharides Conformational activation of CD11b without shedding of L-selectin on circulating human neutrophils J. Leukoc. Biol., November 1, 2007; 82(5): 1115 - 1125. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Choudhary, C. Antoniades, A. F. Brading, A. Galione, K. Channon, and D. P. Taggart Diabetes Mellitus as a Predictor for Radial Artery Vasoreactivity in Patients Undergoing Coronary Artery Bypass Grafting J. Am. Coll. Cardiol., September 11, 2007; 50(11): 1047 - 1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A Hassantash, G. R Omrani, N. Givtaj, and M. Afrakhteh Pharmacological Prevention of the Deleterious Effects of Cardiopulmonary Bypass Asian Cardiovasc Thorac Ann, June 1, 2007; 15(3): 218 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Matsukuma, H. Yamaguchi, and M. Hamawaki Stanford Type A Aortic Dissection with Child B Liver Cirrhosis Asian Cardiovasc Thorac Ann, June 1, 2007; 15(3): e38 - e40. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kulik, F. D. Rubens, D. Gunning, M. E. Bourke, T. G. Mesana, and M. Ruel Radial Artery Graft Treatment With Phenoxybenzamine is Clinically Safe and May Reduce Perioperative Myocardial Injury Ann. Thorac. Surg., February 1, 2007; 83(2): 502 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Kozik and J. S. Tweddell Characterizing the Inflammatory Response to Cardiopulmonary Bypass in Children Ann. Thorac. Surg., June 1, 2006; 81(6): S2347 - S2354. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Teskin, B. S. Uydes-Dogan, Y. Enc, F. I. Alp, D. Kaleli, S. Keser, T. Iyigun, F. Bilgen, S. Dagsali, and O. Ozdemir Comparative Effects of Tolazoline and Nitroprusside on Human Isolated Radial Artery Ann. Thorac. Surg., January 1, 2006; 81(1): 125 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Shanmugam Vasoplegic syndrome--the role of methylene blue Eur. J. Cardiothorac. Surg., November 1, 2005; 28(5): 705 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Kelsall, A. H. Chester, M. Amrani, and D. R.J. Singer C-Type Natriuretic Peptide Relaxes Human Coronary Artery Bypass Grafts Preconstricted by Endothelin-1 Ann. Thorac. Surg., October 1, 2005; 80(4): 1347 - 1351. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fung, R. R. Fiscus, A. P. C. Yim, G. D. Angelini, and A. A. Arifi The Potential Use of Type-5 Phosphodiesterase Inhibitors in Coronary Artery Bypass Graft Surgery Chest, October 1, 2005; 128(4): 3065 - 3073. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Karamlou, J. M. Schultz, C. Silliman, C. Sandquist, J. You, I. Shen, and R. M. Ungerleider Using a Miniaturized Circuit and an Asanguineous Prime to Reduce Neutrophil-Mediated Organ Dysfunction Following Infant Cardiopulmonary Bypass Ann. Thorac. Surg., July 1, 2005; 80(1): 6 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Sersar, M. F. Ismaeil, Y. F. Elghoneimi, and M. A. F. Elgamal Vasomotor dysfunction after cardiac surgery; another look Eur. J. Cardiothorac. Surg., March 1, 2005; 27(3): 529 - 529. [Full Text] [PDF] |
||||
![]() |
K. Cagli, M. M. Ulas, K. Ozisik, A. Kale, V. Bakuy, M. Emir, M. Balci, M. Topbas, E. Sener, and O. Tasdemir The intraoperative effect of pentoxifylline on the inflammatory process and leukocytes in cardiac surgery patients undergoing cardiopulmonary bypass Perfusion, January 1, 2005; 20(1): 45 - 51. [Abstract] [PDF] |
||||
![]() |
G. J Murphy, R. Ascione, and G. D Angelini Coronary artery bypass grafting on the beating heart: surgical revascularization for the next decade? Eur. Heart J., December 1, 2004; 25(23): 2077 - 2085. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hayashi, Y. Sawa, M. Nishimura, N. Fukuyama, H. Ichikawa, S. Ohtake, H. Nakazawa, and H. Matsuda Peroxynitrite, a product between nitric oxide and superoxide anion, plays a cytotoxic role in the development of post-bypass systemic inflammatory response Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 276 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fortier, R.G. DeMaria, Y. Lamarche, O. Malo, A. Denault, F. Desjardins, M. Carrier, and L.P. Perrault Inhaled prostacyclin reduces cardiopulmonary bypass-induced pulmonary endothelial dysfunction via increased cyclic adenosine monophosphate levels J. Thorac. Cardiovasc. Surg., July 1, 2004; 128(1): 109 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hamamoto, M. Suga, T. Nakatani, Y. Takahashi, Y. Sato, S. Inamori, T. Yagihara, and S. Kitamura Phosphodiesterase type 4 inhibitor prevents acute lung injury induced by cardiopulmonary bypass in a rat model Eur. J. Cardiothorac. Surg., May 1, 2004; 25(5): 833 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Englberger, F. F. Immer, F. S. Eckstein, P. A. Berdat, A. Haeberli, and T. P. Carrel Off-Pump coronary artery bypass operation does not increase procoagulant and fibrinolytic activity: preliminary results Ann. Thorac. Surg., May 1, 2004; 77(5): 1560 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hayashida, T. Shoujima, H. Teshima, Y. Yokokura, K. Takagi, H. Tomoeda, and S. Aoyagi Clinical outcome after cardiac operations in patients with cirrhosis Ann. Thorac. Surg., February 1, 2004; 77(2): 500 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bueno, A. C. Resende, R. Melo, V. A. Neto, and N. A. G. Stolf Effects of hypertonic saline-dextran solution in cardiac valve surgery with cardiopulmonary bypass Ann. Thorac. Surg., February 1, 2004; 77(2): 604 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mussa, T. J. Guzik, E. Black, M. A. Dipp, K. M. Channon, and D. P. Taggart Comparative efficacies and durations of action of phenoxybenzamine, verapamil/nitroglycerin solution, and papaverine as topical antispasmodics for radial artery coronary bypass grafting J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1798 - 1805. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hayashi, Y. Sawa, N. Fukuyama, Y. Miyamoto, T. Takahashi, H. Nakazawa, and H. Matsuda Leukocyte-depleted terminal blood cardioplegia provides superior myocardial protective effects in association with myocardium-derived nitric oxide and peroxynitrite production for patients undergoing prolonged aortic crossclamping for more than 120 minutes J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1813 - 1821. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Conant, M. J. Shackcloth, A. Y. Oo, M. R. Chester, A. W. M. Simpson, and W. C. Dihmis Phenoxybenzamine treatment is insufficient to prevent spasm in the radial artery: the effect of other vasodilators J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 448 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Gao, H. Yang, K. Teoh, and R. M.K.W. Lee Detrimental effects of papaverine on the human internal thoracic artery J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 179 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Mayers, T. Hurst, A. Radomski, D. Johnson, S. Fricker, G. Bridger, B. Cameron, M. Darkes, and M. W. Radomski Increased matrix metalloproteinase activity after canine cardiopulmonary bypass is suppressed by a nitric oxide scavenger J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 661 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Hessel II and L. H. Edmunds Jr. Extracorporeal Circulation: Perfusion Systems Card. Surg. Adult, January 1, 2003; 2(2003): 317 - 338. [Full Text] |
||||
![]() |
P. Menasche and L. H. Edmunds Jr. Extracorporeal Circulation: The Inflammatory Response Card. Surg. Adult, January 1, 2003; 2(2003): 349 - 360. [Full Text] |
||||
![]() |
J. W. Hammon Jr. and L. H. Edmunds Jr. Extracorporeal Circulation: Organ Damage Card. Surg. Adult, January 1, 2003; 2(2003): 361 - 388. [Full Text] |
||||
![]() |
R. Salenger, J. S. Gammie, and T. J. Vander Salm Postoperative Care of Cardiac Surgical Patients Card. Surg. Adult, January 1, 2003; 2(2003): 439 - 469. [Full Text] |
||||
![]() |
C. Hsi, H. Cuenoud, B. R Soller, H. Kim, J. Favreau, T. J Vander Salm, and J. M Moran Experimental Coronary Artery Occlusion: Relevance to Off-Pump Cardiac Surgery Asian Cardiovasc Thorac Ann, December 1, 2002; 10(4): 293 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hayashi, Y. Sawa, N. Fukuyama, H. Nakazawa, and H. Matsuda Preoperative Glutamine Administration Induces Heat-Shock Protein 70 Expression and Attenuates Cardiopulmonary Bypass-Induced Inflammatory Response by Regulating Nitric Oxide Synthase Activity Circulation, November 12, 2002; 106(20): 2601 - 2607. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Locker, R. Mohr, Y. Paz, O. Lev-Ran, I. Herz, G. Uretzky, and I. Shapira Pretreatment with {alpha}-adrenergic blockers for prevention of radial artery spasm Ann. Thorac. Surg., October 1, 2002; 74(4): S1368 - 1370. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Y. Szeto, D. Kreisel, G. C. Karakousis, A. Pochettino, D. H. Sterman, R. M. Kotloff, S. M. Arcasoy, D. A. Zisman, N. P. Blumenthal, R. J. Gallop, et al. Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function or clinical outcome J. Thorac. Cardiovasc. Surg., August 1, 2002; 124(2): 241 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hayashi, M. Ohtani, T. Hiraishi, and Y. Kobayashi Postoperative synthetic human atrial natriuretic peptide infusion and oral spironolactone administration for a patient with giant atria and low plasma level of atrial natriuretic peptide J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 206 - 209. [Full Text] [PDF] |
||||
![]() |
F.-U. Sack, B. Reidenbach, A. Schledt, R. Dollner, S. Taylor, M. M. Gebhard, and S. Hagl Dopexamine attenuates microvascular perfusion injury of the small bowel in pigs induced by extracorporeal circulation Br. J. Anaesth., June 1, 2002; 88(6): 841 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Downing, W. A Herzog Jr, J. S. McLaughlin, and T. P. Gilbert Beating-heart mitral valve surgery: Preliminary model and methodology J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1141 - 1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Harrison, A. J. Mellor, J. Clark, and D. R. J. Singer Vasodilator pre-treatment of human radial arteries; comparison of effects of phenoxybenzamine vs papaverine on norepinephrine-induced contraction in vitro Eur. Heart J., December 1, 2001; 22(23): 2209 - 2216. [Abstract] [PDF] |
||||
![]() |
V. R. Conti and C. McQuitty Vasodilation and Cardiopulmonary Bypass : The Role of Bradykinin and the Pulmonary Vascular Endothelium Chest, December 1, 2001; 120(6): 1759 - 1761. [Full Text] [PDF] |
||||
![]() |
M. Cugno, J. Nussberger, P. Biglioli, F. Alamanni, R. Coppola, and A. Agostoni Increase of Bradykinin in Plasma of Patients Undergoing Cardiopulmonary Bypass : The Importance of Lung Exclusion Chest, December 1, 2001; 120(6): 1776 - 1782. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Mayers, T. Hurst, L. Puttagunta, A. Radomski, T. Mycyk, G. Sawicki, D. Johnson, and M. W. Radomski Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts J. Thorac. Cardiovasc. Surg., October 1, 2001; 122(4): 746 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kottke-Marchant and S. Sapatnekar Hemostatic Abnormalities in Cardiopulmonary Bypass: Pathophysiologic and Transfusion Considerations Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 187 - 206. [Abstract] [PDF] |
||||
![]() |
E. Appachi and E. B. Mossad Inflammatory Mediators and S-100{beta} Protein Concentrations in Neonates and Infants With Congenital Heart Disease Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 256 - 261. [Abstract] [PDF] |
||||
![]() |
Y. Hayashi, K. Kagisaki, T. Yamaguchi, T. Sakaguchi, Y. Naka, Y. Sawa, S. Ohtake, and H. Matsuda Clinical application of vacuum-assisted cardiopulmonary bypass with a pressure relief valve Eur. J. Cardiothorac. Surg., September 1, 2001; 20(3): 621 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hayashi, Y. Sawa, S. Ohtake, N. Fukuyama, H. Nakazawa, and H. Matsuda Peroxynitrite formation from human myocardium after ischemia-reperfusion during open heart operation Ann. Thorac. Surg., August 1, 2001; 72(2): 571 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Joffs, C. A. Walker, J. W. Hendrick, D. J. Fary, D. K. Almany, J. N. Davis, A. T. Goldberg, F. A. Crawford Jr, and F. G. Spinale Endothelin receptor subtype A blockade selectively reduces pulmonary pressure after cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 365 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hayashi, Y. Sawa, N. Fukuyama, H. Nakazawa, and H. Matsuda Inducible nitric oxide production is an adaptation to cardiopulmonary bypass-induced inflammatory response Ann. Thorac. Surg., July 1, 2001; 72(1): 149 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Iida, M. Iida, M. Takenaka, A. Oda, M. Uchida, H. Fujiwara, and S. Dohi The Effects of Alpha-Human Atrial Natriuretic Peptide and Milrinone on Pial Vessels During Blood-Brain Barrier Disruption in Rabbits Anesth. Analg., July 1, 2001; 93(1): 177 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mathieu, J. Dupuis, M. Carrier, P. Cernacek, M. Pellerin, L. P. Perrault, R. Cartier, J. Taillefer, and L. C. Pelletier Pulmonary metabolism of endothelin 1 during on-pump and beating heart coronary artery bypass operations J. Thorac. Cardiovasc. Surg., June 1, 2001; 121(6): 1137 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mekontso-Dessap, R. Houel, C. Soustelle, M. Kirsch, D. Thebert, and D. Y. Loisance Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function Ann. Thorac. Surg., May 1, 2001; 71(5): 1428 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Joffs, H. R. Gunasinghe, M. M. Multani, B. H. Dorman, J. M. Kratz, A. J. Crumbley III, F. A. Crawford Jr, and F. G. Spinale Cardiopulmonary bypass induces the synthesis and release of matrix metalloproteinases Ann. Thorac. Surg., May 1, 2001; 71(5): 1518 - 1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Liu, H. S. Floten, A. P. Furnary, A. P.C. Yim, and G.-W. He Effects of potassium channel opener aprikalim on the receptor-mediated vasoconstriction in the human internal mammary artery Ann. Thorac. Surg., February 1, 2001; 71(2): 636 - 641. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Mojcik and J. H. Levy Aprotinin and the systemic inflammatory response after cardiopulmonary bypass Ann. Thorac. Surg., February 1, 2001; 71(2): 745 - 754. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hayashida, S. Chihara, H. Kashikie, E. Tayama, S. Yokose, K. Akasu, and S. Aoyagi Effects of intraoperative administration of atrial natriuretic peptide Ann. Thorac. Surg., October 1, 2000; 70(4): 1319 - 1326. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hayashi, Y. Sawa, M. Nishimura, S. J. Tojo, N. Fukuyama, H. Nakazawa, and H. Matsuda P-selectin participates in cardiopulmonary bypass-induced inflammatory response in association with nitric oxide and peroxynitrite production J. Thorac. Cardiovasc. Surg., September 1, 2000; 120(3): 558 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Borgdorff, G. van den Bos, and G. J. Tangelder Extracorporeal circulation can induce hypotension by both blood-material contact and pump-induced platelet aggregation J. Thorac. Cardiovasc. Surg., July 1, 2000; 120(1): 12 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Grossi, K. Kallenbach, S. Chau, C. C. Derivaux, M. G. Aguinaga, B. M. Steinberg, D. Kim, S. Iyer, M. Tayyarah, M. Artman, et al. Impact of heparin bonding on pediatric cardiopulmonary bypass: a prospective randomized study Ann. Thorac. Surg., July 1, 2000; 70(1): 191 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
J |